MR Imaging Analysis of Non-Measurable Enhancing Lesions Newly Appearing after Concomitant Chemoradiotherapy in Glioblastoma Patients for Prognosis Prediction

Míreanna Comhchosúla

• Prognosis Prediction of Measurable Enhancing Lesion after Completion of Standard Concomitant Chemoradiotherapy and Adjuvant Temozolomide in Glioblastoma Patients: Application of Dynamic Susceptibility Contrast Perfusion and Diffusion-Weighted Imaging
  le: Kim, Jae Hyun, et al.
  Foilsithe: (2014)
• Prognosis prediction of measurable enhancing lesion after completion of standard concomitant chemoradiotherapy and adjuvant temozolomide in glioblastoma patients: application of dynamic susceptibility contrast perfusion and diffusion-weighted imaging.
  le: Jae Hyun Kim, et al.
  Foilsithe: (2014-01-01)
• Prediction of Response to Concurrent Chemoradiotherapy with Temozolomide in Glioblastoma: Application of Immediate Post-Operative Dynamic Susceptibility Contrast and Diffusion-Weighted MR Imaging
  le: Lee, Eun Kyoung, et al.
  Foilsithe: (2015)
• Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis
  le: Roh, Tae Hoon, et al.
  Foilsithe: (2017)
• BI-17 EARLY COGNITIVE FUNCTION TESTS PREDICT EARLY PROGRESSION IN NEWLY-DIAGNOSED GLIOBLASTOMA
  le: Lee, Soon-Tae, et al.
  Foilsithe: (2014)